FTSE MIB
33.629,21 -107,19 (-0,32%) Dow Jones
38.675,68 +450,02 (+1,18%) Nasdaq
16.156,33 +315,37 (+1,99%) Nikkei 225
38.236,07 -37,98 (-0,10%) Petrolio
77,99 -0,96 (-1,22%) Bitcoin EUR
59.693,11 +4.712,75 (+8,57%)
Athira Pharma, Inc. (ATHA)
Dopo ore:
| Chiusura precedente | 1,9600 |
| Aperto | 2,0000 |
| Denaro | 1,9300 x 100 |
| Lettera | 1,9800 x 300 |
| Min-Max giorno | 1,9400 - 2,0500 |
| Intervallo di 52 settimane | 1,3300 - 4,2980 |
| Volume | |
| Media Volume | 350.266 |
| Capitalizzazione | 75,12M |
| Beta (5 anni mensile) | 2,78 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -3,0900 |
| Prossima data utili | 09 mag 2024 - 13 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 7,42 |
GlobeNewswireAthira Pharma Presents Preclinical Data Further Supporting the Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
New results support the neuroprotective effects of ATH-1105 in preclinical models of ALS, as indicated by consistent reduction in plasma neurofilament light chain (NfL) levels and preservation of motor function Data presented at invitational Northeast ALS Consortium (NEALS) meeting BOTHELL, Wash., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodege
- GlobeNewswire
Athira Pharma to Participate in Upcoming October Conferences
BOTHELL, Wash., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in the following upcoming investor conferences in October. Goldman Sachs Alzheimer’s Disease DayFormat: Panel Presentation Date and Time: Tuesday, October 3, 2023, from 10:00 a.m. ET- 11:00 a.m. ET Location: Goldman
- GlobeNewswire
Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
BOTHELL, Wash., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in a panel presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference taking place from September 26-28, 2023 in New York City. Details are as follows: 2023 Cantor Fitzgerald Global Healthcare Conferenc
